BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 16109079)

  • 1. Octreotide therapy for chylous ascites in a chronic dialysis patient.
    Lee PH; Lin CL; Lai PC; Yang CW
    Nephrology (Carlton); 2005 Aug; 10(4):344-7. PubMed ID: 16109079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report.
    Berzigotti A; Magalotti D; Cocci C; Angeloni L; Pironi L; Zoli M
    Dig Liver Dis; 2006 Feb; 38(2):138-42. PubMed ID: 16389001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chylous ascites in gynecologic malignancies: cases report and literature review.
    Baiocchi G; Faloppa CC; Araujo RL; Fukazawa EM; Kumagai LY; Menezes AN; Badiglian-Filho L
    Arch Gynecol Obstet; 2010 Apr; 281(4):677-81. PubMed ID: 19685063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chylous ascites in a patient treated with intermittent peritoneal dialysis.
    Humayun HM; Daugirdas JT; Ing TS; Leehey DJ; Gandhi VC; Popli S
    Artif Organs; 1984 Aug; 8(3):358-60. PubMed ID: 6477204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative chylous ascites in a neonate treated successfully with octreotide: bile sludge and cholestasis.
    Andreou A; Papouli M; Papavasiliou V; Badouraki M
    Am J Perinatol; 2005 Nov; 22(8):401-4. PubMed ID: 16283598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chylous ascites in 12 patients undergoing peritoneal dialysis].
    Poux JM; Bénévent D; Guiserix J; Le Meur Y; Lagarde C; Leroux-Robert C
    Nephrologie; 1994; 15(3):201-5. PubMed ID: 7969712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chylous ascites after a living-donor liver graft, effectively treated in a child with octreotide.
    Ünlüsoy Aksu A; Demirtaş Z; Eğritaş Gürkan Ö; Dalgıç B; Sözen H; Dalgıç A
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():173-4. PubMed ID: 24635821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of refractory chylous ascites after Kasai portoenterostomy using octreotide.
    Hwang JB; Choi SO; Park WH
    J Pediatr Surg; 2004 Dec; 39(12):1806-7. PubMed ID: 15616936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chylorrhea after left nephroureterectomy].
    Osaka K; Kobayashi M; Fujikawa A; Ouchi H; Iwasaki A
    Hinyokika Kiyo; 2009 Sep; 55(9):563-6. PubMed ID: 19827619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide therapy for the management of refractory chylous ascites after a staging operation for endometrial adenocarcinoma.
    Kim EA; Park H; Jeong SG; Lee C; Lee JM; Park CT
    J Obstet Gynaecol Res; 2014 Feb; 40(2):622-6. PubMed ID: 24118223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chyloperitoneum in a peritoneal dialysis patient.
    Levy RI; Wenk RE
    Am J Kidney Dis; 2001 Sep; 38(3):E12. PubMed ID: 11532714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic chylous ascites treated with total parenteral nutrition and octreotide. A case report and review of the literature.
    Yildirim AE; Altun R; Can S; Ocal S; Akbaş E; Korkmaz M; Selçuk H; Yilmaz U
    Eur J Gastroenterol Hepatol; 2011 Oct; 23(10):961-3. PubMed ID: 21817913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chylous ascites after hepatopancreatobiliary surgery.
    Kuboki S; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Miyazaki M
    Br J Surg; 2013 Mar; 100(4):522-7. PubMed ID: 23288577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chylous ascites caused by portal vein thrombosis treated with octreotide.
    Leong RW; House AK; Jeffrey GP
    J Gastroenterol Hepatol; 2003 Oct; 18(10):1211-3. PubMed ID: 12974913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of the treatment of octreotide on chylous ascites after liver cirrhosis.
    Zhou DX; Zhou HB; Wang Q; Zou SS; Wang H; Hu HP
    Dig Dis Sci; 2009 Aug; 54(8):1783-8. PubMed ID: 19051030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydropyridine type calcium channel blocker-induced turbid dialysate in patients undergoing peritoneal dialysis.
    Yoshimoto K; Saima S; Nakamura Y; Nakayama M; Kubo H; Kawaguchi Y; Nishitani H; Nakamura Y; Yasui A; Yokoyama K; Kuriyama S; Shirai D; Kugiyama A; Hayano K; Fukui H; Horigome I; Amagasaki Y; Tsubakihara Y; Kamekawa T; Ando R; Tomura S; Okamoto R; Miwa S; Koyama T; Echizen H
    Clin Nephrol; 1998 Aug; 50(2):90-3. PubMed ID: 9725779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chylous ascites: an unusual complication of peritoneal dialysis].
    DE Paula A; Jimeno A; Largo ME; Gago P; Díez JL; Bustamante J
    Rev Clin Esp; 1975 Nov; 139(4):333-8. PubMed ID: 1208913
    [No Abstract]   [Full Text] [Related]  

  • 19. Chylous ascites: an unusual complication of peritoneal dialysis. A case report and literature review.
    Cheung CK; Khwaja A
    Perit Dial Int; 2008; 28(3):229-31. PubMed ID: 18474912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of refractory chylous effusions of unknown origin with octreotide.
    Zeller L; Etzion Y; Hertzanu Y; Schlaeffer F; Sukenik S
    Isr Med Assoc J; 2008; 10(8-9):655-6. PubMed ID: 18847174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.